Additionally, LXA4 reduced neutrophil degranulation and release of myeloperoxidase in a concentration-dependent manner from neutrophils isolated from healthy volunteers and in patients with mild and moderate–severe bronchiectasis (online supplemental figure S5). Here, MPO is linked to bronchiectasis.